Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mucopolysaccharidoses and the eye.

Jane L Ashworth1, Susmito Biswas, Ed Wraith

  • 1Manchester Royal Eye Hospital, Oxford Road, Manchester M13 9WH, UK.

Survey of Ophthalmology
|January 18, 2006
PubMed
Summary

Mucopolysaccharidoses (MPSs) are rare genetic disorders causing glycosaminoglycan buildup. This review covers MPS systemic and ocular symptoms, and emerging treatments like enzyme replacement therapy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical Spectrum and Genetics of Ocular Manifestations in Muscle Eye Brain Disease: A Literature Review.

Seminars in ophthalmology·2026
Same author

Clinical practice recommendations for the diagnosis and management of nephropathic cystinosis.

Nature reviews. Nephrology·2026
Same author

Role of Ethnicity and Age in Corneal Curvature and Thickness Changes Following Corneal Cross-Linking for Keratoconus.

Translational vision science & technology·2026
Same author

Outcomes of Paediatric Glaucoma Surgery: Insights From a Five-Year Retrospective Study in Manchester.

Cureus·2025
Same author

Cystadrops<sup>®</sup> Eye Drops for the Management of Ocular Cystinosis in Patients Aged 6 Months to < 2 Years.

Ophthalmology and therapy·2025
Same author

Update on pediatric cataract surgery.

Asia-Pacific journal of ophthalmology (Philadelphia, Pa.)·2025

Area of Science:

  • Genetics
  • Metabolic Disorders
  • Ophthalmology

Background:

  • Mucopolysaccharidoses (MPSs) are inherited lysosomal storage diseases.
  • Caused by enzyme defects leading to glycosaminoglycan accumulation.
  • Encompasses various subtypes like MPS I (Hurler) and MPS II (Hunter).

Purpose of the Study:

  • To review the systemic and ocular manifestations of MPS.
  • To discuss novel treatment modalities for MPS.
  • To outline the ophthalmic management strategies for MPS patients.

Main Methods:

  • Literature review of systemic and ocular manifestations.
  • Analysis of current and emerging treatment options.
  • Discussion of ophthalmic care guidelines for MPS.

Main Results:

  • MPS presents with diverse systemic issues (respiratory, skeletal, neurological, cardiac).
  • Ocular complications are frequent, including corneal opacification, retinopathy, and glaucoma.
  • Bone marrow transplant and enzyme replacement therapy show improved prognosis.

Conclusions:

  • MPS requires comprehensive management addressing systemic and ocular aspects.
  • Early diagnosis and intervention are crucial for better outcomes.
  • Ongoing research into treatments like enzyme replacement therapy offers hope.

Related Experiment Videos